Searched for
WOCKHARDT UK BUSINESS
Wockhardt Ltd dumps US generic pharma segment after losses, bets on antibiotics and insulinWockhardt Ltd has decided to shut down its loss-making US generics business to channel its energy and funds into developing new antibiotics...- Wockhardt shares jump 17%, hit fresh 52-week highWockhardt extended its winning streak for the third straight session, drawing strong investor interest with trading volumes surging over 4....
- Wockhardt's COVID-19 vaccines supply deal with UK Govt extended for 6 monthsOn the development, UK International Trade Secretary Liz Truss said, "It brings important investment to the local area, bringing jobs and s...
- Wockhardt Q3 results: Net profit up 69% to Rs 32 croreTotal income stood at Rs 864.56 crore for the quarter under consideration, up 12.89 per cent, as against Rs 765.80 crore for the same perio...
- Wockhardt surges 10% on signing Covid-19 deal with UK governmentAs per the terms of the agreement, Wockhardt has reserved manufacturing capacity to allow for the supply of multiple vaccines to the UK gov...
- Wockhardt Q4 net up 26% at Rs 43 crore; to raise Rs 1,200 croreDrug firm Wockhardt today reported a 25.88 per cent rise in consolidated net profit to Rs 42.90 crore for the quarter ended March 31.
- Wockhardt Q2 net zooms to Rs 108 croreThe company had posted a net profit of Rs 3.63 crore during the corresponding period of the previous fiscal, Wockhardt said in a filing to ...
- Wockhardt to enhance R&D capabilities in drug innovation: MDPharma firm Wockhardt will continue to strengthen its R&D capabilities to develop innovative and technologically advanced medicines, a top ...
- Zoher Sihorwala to head Wockhardt's regulatory unitMumbai-based pharmaceutical company Wockhardt has appointed Zoher Sihorwala to head its regulatory and compliance division, a senior execut...
- Wockhardt drops 5%, locked in lower circuit as UK health regulator withdraws certificationThe stock is now locked in lower circuit at Rs 499.30. It has lost nearly 10% in the month of October as compared to over 60% fall so far i...
- UK health regulator withdraws certification of Wockhardt unitThe impact of the same on existing business will only be known once the company receives further communication from UKMHRA, Wockhardt said.
- Wockhardt Q1 Net dips 14 per cent to Rs 323 croreNet sales rose to Rs 1,358.37 crore for the first quarter, compared to Rs 1,341.44 crore during the same period of previous fiscal.
- UK regulator issues import alert on Wockhardt's Waluj plant in MaharashtraDrug firm Wockhardt today said UK Medicines and MHRA has imposed an import alert on Wockhardt's export-oriented Unit plant at Waluj in Maha...
- Wockhardt Q3 net zooms two-fold to Rs 428 croreThe company had posted a net profit of Rs 213 crore in the same period of previous fiscal.
- Wockhardt clears the debt mess, posts 95% YoY growth in Q1The company's consolidated revenues grew by 35% at Rs 1426 cr as against Rs 1053 cr last year, during the same quarter.
- Wockhardt June quarter loss narrows to Rs 116 crThe Mumbai-based company had posted a net loss of Rs 189.87 crore in the corresponding quarter of the previous fiscal.
- Wockhardt plans CRAM play to bag big US, European dealsDomestic pharma major Wockhardt has decided to enter the lucrative contract manufacturing (CRAM) space from the next fiscal.
- Wockhardt buys French co for Rs 1,090 crWockhardt has acquired Negma Laboratories in cash - a deal that would give it access to the European mkt.
- Wockhardt buys out Irish co for Rs 690 crMumbai-based pharmaceutical firm Wockhardt on Tuesday said the company has acquired Pinewood Laboratories, one of the largest and fastest g...
- Wockhardt acquires Pinewood for Rs 686 crThe acquisition is a strategic fit for Wockhardt UK as Pinewood's liquids and creams business complements its strengths in injectable and s...
Load More
